Unknown

Dataset Information

Multiplex Screening for Interacting Compounds in Paediatric Acute Myeloid Leukaemia.


ABSTRACT: Paediatric acute myeloid leukaemia (AML) is a heterogeneous disease characterised by the malignant transformation of myeloid precursor cells with impaired differentiation. Standard therapy for paediatric AML has remained largely unchanged for over four decades and, combined with inadequate understanding of the biology of paediatric AML, has limited the progress of targeted therapies in this cohort. In recent years, the search for novel targets for the treatment of paediatric AML has accelerated in parallel with advanced genomic technologies which explore the mutational and transcriptional landscape of this disease. Exploiting the large combinatorial space of existing drugs provides an untapped resource for the identification of potential combination therapies for the treatment of paediatri

SUBMITTER: Cairns LV 

PROVIDER: S-EPMC8468645 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature